bexarotene has been researched along with angiotensin ii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furgeson, SB; Horita, H; Lehman, AM; Montford, JR; Nemenoff, RA; Ostriker, AC; Weiser-Evans, MC | 1 |
| Collado, A; Escudero, P; Gonzalez-Navarro, H; Hermenegildo, C; Martinez de Marañón, A; Peiró, C; Piqueras, L; Sanz, MJ | 1 |
| Escudero, P; Ferrando, C; Furio, E; Gonzalez-Navarro, H; Juez, M; Navarro, A; Piqueras, L; Sanz, MJ | 1 |
3 other study(ies) available for bexarotene and angiotensin ii
| Article | Year |
|---|---|
Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
Topics: Actins; Angiotensin II; Animals; Bexarotene; Calcium-Binding Proteins; Calponins; Cells, Cultured; Chemokine CCL2; Gene Expression; Inflammation; Male; MAP Kinase Signaling System; Microfilament Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Signal Transduction; Tetrahydronaphthalenes | 2014 |
Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
Topics: Angiotensin II; Anticarcinogenic Agents; Arteries; Bexarotene; Cell Adhesion; Cell Line; Fluorobenzenes; Humans; Leukocytes, Mononuclear; Membrane Proteins; NADPH Oxidase 5; NADPH Oxidases; Nitric Oxide; Peroxisome Proliferator-Activated Receptors; Pyrimidines; Retinoid X Receptors; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Tetrahydronaphthalenes | 2015 |
Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Bexarotene; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Rosuvastatin Calcium; Signal Transduction; Tetrahydronaphthalenes | 2015 |